VP, Global Franchise Head - Hematology asset, Lymphoma & Leukemia

At AstraZeneca we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. We're focused on the potential of science to address the unmet needs of patients around the world. We commit to those areas where we think we can really change the course of medicine and bring big new ideas to life.

Reporting into the VP, Global Head, Hematology Franchise and Cell Therapy and sitting on the Leadership Team, the Global Franchise Head Hematology asset and Lymphoma & Leukemia is responsible for leading and delivering Lymphoma & Leukemia therapeutic area strategy and leading the hematology asset commercialization strategy and execution globally, to achieve revenue and earning objectives, to maximize the overall hematology and oncology commercial promise and ultimately deliver life changing care to patients. The position has full P&L responsibility for the relevant Franchise globally.

The Global Franchise Head will have the opportunity to continue the development of one of AstraZeneca's leading franchises in cancer care, shaping and leading Global launches with the potential to help hundreds of thousands of patients. In this role, you'll play a pivotal role in channelling our scientific capabilities to make a positive impact on changing patients' lives and truly change the paradigm of care in cancer.

The position requires strong strategic thinking to assess a range of variables including market trends and opportunities, competition, research advances, etc., to develop strong near- and long-term strategies for the Franchise. Strong analytical skills combined with a strong market orientation to identify breakthrough opportunities are a must. This role will work closely with our Business Development team and our R&D teams to support commercial opportunities and identify key business and clinical opportunities to expand our leadership across Lymphoma and Leukaemia.

Accountabilities :

• Accountable for overall hematology asset commercial and development strategies across all indications.
• Develop resources and programs to support global launches.
• Partner with core markets to prepare for unprecedented number of Phase III read outs and launches for hematology asset.
• Lead Integrative Business Team(s) to manage the life cycle of our medicines.
• Deliver and execute Phase 3 / pre-launch marketing strategy & execution plans for hematology asset trials.
• Lead and deliver commercial strategy for multiple additional indications (lifecycle management).
• Work with extended team to deliver a sustainable pricing and access strategy for multiple indications.
• Collaborate with Oncology R&D to lead hematology asset and lead the tumor area strategy across lymphoma and leukemia for the Oncology Business Unit.

Ideal Candidate attributes :

Requirements : Education

Experience

Knowledge

The annual base pay for this position ranges from $330,263 - $495,395. Hourly and salaried non-exempt employees will also be paid overtime pay when working qualifying overtime hours. Base pay offered may vary depending on multiple individualized factors, including market location, job-related knowledge, skills, and experience. In addition, our positions offer a short-term incentive bonus opportunity; eligibility to participate in our equity-based long-term incentive program (salaried roles), to receive a retirement contribution (hourly roles), and commission payment eligibility (sales roles). Benefits offered included a qualified retirement program [401(k) plan]; paid vacation and holidays; paid leaves; and, health benefits including medical, prescription drug, dental, and vision coverage in accordance with the terms and conditions of the applicable plans. Additional details of participation in these benefit plans will be provided if an employee receives an offer of employment. If hired, employee will be in an "at-will position" and the Company reserves the right to modify base pay (as well as any other discretionary payment or compensation program) at any time, including for reasons related to individual performance, Company or individual department / team performance, and market factors.

Date Posted

17-Nov-2025

Closing Date

Our mission is to build an inclusive environment where equal employment opportunities are available to all applicants and employees. In furtherance of that mission, we welcome and consider applications from all qualified candidates, regardless of their protected characteristics. If you have a disability or special need that requires accommodation, please complete the corresponding section in the application form.